Navigation Links
GenVault Corporation Launches GenTegra(TM) DNA

Proprietary inorganic matrix for dry state room temperature transport and

storage of purified DNA

CARLSBAD, Calif., Oct. 8 /PRNewswire/ -- GenVault Corporation, the leader in dry, room temperature biosample management, announces the launch of an innovative new product, GenTegra(TM) DNA. GenTegra DNA is a proprietary inorganic matrix with built-in oxidative protection and antimicrobial activity for dry, room temperature transport and storage of purified DNA. GenTegra DNA is provided in ready to use aliquots, and purified DNA dried within GenTegra DNA is simply and fully resolubilized with water for direct downstream molecular analysis.

"GenVault's goal is to provide solutions that enable efficiency in biosample management for genomic-based medicine and research. GenTegra DNA is the first of GenVault's next generation of core innovative technologies that will include a broad range of sample types," said David Wellis, Ph.D., CEO of GenVault.

"Our goal at the Eccles Institute of Human Genetics of developing rapid and large-scale genotyping techniques for identifying genetic variations that confer predispositions to human disorders and traits is well served by innovative technologies such as GenTegra(TM) DNA. Preservation of DNA integrity in a dry state room temperature environment such as GenTegra benefits large scale studies and any worldwide genomic community efforts," said Dr. Mark F. Leppert, Ph.D, Professor and Co-Chair, Department of Human Genetics, University of Utah.

"Our work at Scripps Translational Science Institute benefits from innovative technologies such as GenTegra(TM) for storing and transporting DNA samples with our collaborators. The genotyping results of frozen samples and samples stored with GenTegra at room temperature were identical, indicating that recovered samples were of high purity and quality," said Sarah Shaw Murray, Ph.D., Director of Genetics, Scripps Genomic Medicine, The Scripps Translational Science Institute.

"Wildlife species conservation efforts are impacted by improvements in genetic testing and management of increasing numbers of purified DNA samples. GenTegra(TM) DNA Tubes provide an innovative method of storing DNA safely at room temperature. DNA integrity is preserved and pure, high molecular weight DNA is easily recovered for immediate use in downstream applications. Current and future studies in our laboratory on large mammals from North America and Africa will benefit from innovative storage and shipping solutions such as GenTegra DNA," said Natalie Halbert, Ph.D, Research Assistant Professor, Conservation Genetics and Genomics, Texas A&M University.

"Our collaborative initiatives will benefit a great deal from innovative technologies like GenTegra, especially in sharing and storage of biosamples from global cohorts. We were pleased with the high yield and quality of the DNA that we recovered from the GenTegra DNA tubes," said Maurine Hobbs, Ph.D., Assistant Professor, Division of Infectious Diseases at the University of Utah.

Maintaining DNA integrity as well as simplifying laboratory workflows is no longer a concern with long term storage at room temperature. GenTegra(TM) DNA ensures sample stability and is compatible with the most demanding molecular assays. GenTegra along with the full suite of GenVault products provide smart, environmentally and financially sustainable solutions which complement and enhance existing cryostorage systems.

For more information on GenTegra DNA, please visit our GenTegra DNA webpage at:

About GenVault

GenVault is the global leader in providing biosample workflow, transport, and storage solutions for genomic medicine, discovery and identification. Today, GenVault is empowering over 150 pharmaceutical companies, medical centers, academic institutions and law enforcement agencies to more fully leverage the rapidly growing genomics industry. As a scalable and reliable complement to traditional freezers and DNA purification systems, the company's dry state platform enables the extraction, preservation, recovery, and distribution of DNA at room temperature. Future systems will accommodate proteins and RNA to provide a comprehensive solution. From the GenPlate to the Dynamic Archive, GenVault is continuously developing and refining best practices for biomolecule sample management and preservation. For more information visit GenVault at .


Rene Nunez, Senior Product Marketing Manager

GenVault Corporation

(760) 268-5200

SOURCE GenVault Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. GenVault Expands Scientific Advisory Board
2. Paul J. Mirabella, President and CEO of Naviscan PET Systems Inc., Joins GenVaults Board of Directors
3. Mark Ostrowski Joins GenVault as Vice President of Sales and Marketing
4. McGill University Purchases GenVaults Personal Archive System to Manage Rare Cancer Samples
5. GenVault and the National Center for Forensic Science to Present Novel Technology for Room Temperature Storage of RNA
6. David Barker, Former Illumina CSO, Joins GenVaults Scientific Advisory Board
7. GenVault Partnership with Genome Quebec Brings $3.3 Million Sale of Dynamic Archive Product
8. AMERIGROUP Corporation to Discuss Third Quarter Earnings on October 23
9. Environmental Tectonics Corporation Announces the Placement of Two Monoplace Hyperbaric Chambers at Saint Barnabas Medical Center in New Jersey
10. Alba Therapeutics Corporation Announces Promotions
11. Verenium Corporation to Present at the William Blair & Company 2008 Small-Cap Growth Stock Conference
Post Your Comments:
(Date:6/27/2016)... ... 27, 2016 , ... Cancer experts from Austria, Hungary, Switzerland, ... a new and helpful biomarker for malignant pleural mesothelioma. Surviving Mesothelioma has just ... now. , Biomarkers are components in the blood, tissue or body fluids ...
(Date:6/27/2016)... , June 27, 2016  Liquid Biotech ... the funding of a Sponsored Research Agreement with ... tumor cells (CTCs) from cancer patients.  The funding ... CTC levels correlate with clinical outcomes in cancer ... data will then be employed to support the ...
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of ... the Cary 5000 and the 6000i models are higher end machines that use the ... of the spectrophotometer’s light beam from the bottom of the cuvette holder. , ...
(Date:6/23/2016)... Mass. , June 23, 2016   ... development of novel compounds designed to target cancer ... napabucasin, has been granted Orphan Drug Designation from ... the treatment of gastric cancer, including gastroesophageal junction ... stemness inhibitor designed to inhibit cancer stemness pathways ...
Breaking Biology Technology:
(Date:4/13/2016)... , April 13, 2016  IMPOWER physicians supporting Medicaid ... setting a new clinical standard in telehealth thanks to ... leveraging the higi platform, IMPOWER patients can routinely track ... and body mass index, and, when they opt in, ... convenient visit to a local retail location at no ...
(Date:3/29/2016)... 2016 LegacyXChange, Inc. (OTC: ... SelectaDNA/CSI Protect are pleased to announce our successful effort ... variety of writing instruments, ensuring athletes signatures against counterfeiting ... from athletes on LegacyXChange will be assured of ongoing ... Bill Bollander , CEO states, "By ...
(Date:3/22/2016)... , PROVO and ... Newborn Screening Ontario (NSO), which operates the highest sample ... molecular testing, and Tute Genomics and UNIConnect, leaders in ... respectively, today announced the launch of a project to ... (NGS) testing panel. NSO has been ...
Breaking Biology News(10 mins):